Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery

PURPOSE: Trastuzumab is effective in early and advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, few studies have reported the effect of trastuzumab on ipsilateral breast tumor recurrence (IBTR), whose incidence is higher in the HER2-positive subtype than in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheun, Jong-Ho, Won, Jiyoung, Jung, Ji Gwang, Kim, Hong-Kyu, Han, Wonshik, Lee, Han-Byoel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250103/
https://www.ncbi.nlm.nih.gov/pubmed/34190441
http://dx.doi.org/10.4048/jbc.2021.24.e33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250103/
https://www.ncbi.nlm.nih.gov/pubmed/34190441
http://dx.doi.org/10.4048/jbc.2021.24.e33

Ejemplares similares